chr18-45063547-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015559.3(SETBP1):​c.4640C>A​(p.Thr1547Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00161 in 1,368,854 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1547S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0038 ( 7 hom., cov: 24)
Exomes 𝑓: 0.0014 ( 54 hom. )

Consequence

SETBP1
NM_015559.3 missense

Scores

1
3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.34

Publications

1 publications found
Variant links:
Genes affected
SETBP1 (HGNC:15573): (SET binding protein 1) This gene encodes a protein which contains a several motifs including a ski homology region and a SET-binding region in addition to three nuclear localization signals. The encoded protein has been shown to bind the SET nuclear oncogene which is involved in DNA replication. Mutations in this gene are associated with Schinzel-Giedion midface retraction syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
SETBP1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal dominant 29
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Schinzel-Giedion syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • intellectual disability-expressive aphasia-facial dysmorphism syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019431114).
BP6
Variant 18-45063547-C-A is Benign according to our data. Variant chr18-45063547-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 159882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0513 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SETBP1NM_015559.3 linkc.4640C>A p.Thr1547Asn missense_variant Exon 6 of 6 ENST00000649279.2 NP_056374.2 Q9Y6X0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SETBP1ENST00000649279.2 linkc.4640C>A p.Thr1547Asn missense_variant Exon 6 of 6 NM_015559.3 ENSP00000497406.1 Q9Y6X0-1

Frequencies

GnomAD3 genomes
AF:
0.00377
AC:
489
AN:
129802
Hom.:
7
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00166
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0352
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000114
Gnomad OTH
AF:
0.00643
GnomAD2 exomes
AF:
0.0105
AC:
1134
AN:
107896
AF XY:
0.00783
show subpopulations
Gnomad AFR exome
AF:
0.000203
Gnomad AMR exome
AF:
0.0534
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000856
Gnomad OTH exome
AF:
0.00726
GnomAD4 exome
AF:
0.00139
AC:
1717
AN:
1239008
Hom.:
54
Cov.:
23
AF XY:
0.00116
AC XY:
707
AN XY:
610886
show subpopulations
African (AFR)
AF:
0.000674
AC:
18
AN:
26726
American (AMR)
AF:
0.0535
AC:
1580
AN:
29534
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20244
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
67628
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44924
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3488
European-Non Finnish (NFE)
AF:
0.0000477
AC:
46
AN:
964446
Other (OTH)
AF:
0.00144
AC:
73
AN:
50846
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
69
138
208
277
346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00379
AC:
492
AN:
129846
Hom.:
7
Cov.:
24
AF XY:
0.00425
AC XY:
265
AN XY:
62404
show subpopulations
African (AFR)
AF:
0.00166
AC:
57
AN:
34430
American (AMR)
AF:
0.0354
AC:
417
AN:
11788
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3138
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4372
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3934
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8034
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
242
European-Non Finnish (NFE)
AF:
0.000114
AC:
7
AN:
61346
Other (OTH)
AF:
0.00637
AC:
11
AN:
1728
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000404
Hom.:
0
Bravo
AF:
0.00620
ExAC
AF:
0.00384
AC:
365

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 28, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.17
T;T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.50
N
LIST_S2
Benign
0.49
.;T
MetaRNN
Benign
0.0019
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.1
L;L
PhyloP100
1.3
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.33
.;N
REVEL
Benign
0.068
Sift
Uncertain
0.0090
.;D
Sift4G
Uncertain
0.043
.;D
Polyphen
0.23
B;B
Vest4
0.065
MPC
1.6
ClinPred
0.027
T
GERP RS
4.8
Varity_R
0.16
gMVP
0.17
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201973930; hg19: chr18-42643512; API